TLDR: The AIRIS 2025 symposium, co-hosted by the Republic of Korea’s Ministry of Food and Drug Safety (MFDS) and the World Health Organization (WHO), is set to gather global experts from September 10-12, 2025, at INSPIRE RESORT INCHEON. The event aims to foster dialogue and develop regulatory frameworks for the safe and ethical application of artificial intelligence in medical product development and regulation.
Global leaders and experts are preparing to converge at the AIRIS 2025 symposium, a pivotal event focused on advancing the safe and ethical integration of artificial intelligence (AI) within the healthcare sector. Co-organized by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and the World Health Organization (WHO), the symposium is scheduled to take place from September 10 to 12, 2025, at the INSPIRE RESORT INCHEON.
The primary objective of AIRIS 2025 is to establish a robust platform for regulators, industry stakeholders, and academia to exchange critical insights and innovative ideas. The discussions will center on the effective utilization of AI in the development and regulation of medical products, ensuring that technological advancements align with ethical considerations and patient safety.
The event boasts an impressive roster of speakers, reflecting its global scope and multidisciplinary approach. Attendees will hear from distinguished figures such as Nobel laureate David Baker, a professor at The Institute for Protein Design, The University of Washington. Other notable speakers include Tala Fakhouri, Vice President at Parexel; Bruce Church, Chief Mathematics Officer and EVP of Research and Early Development at Aitia; Pat Baird, Senior Regulatory Specialist at Philips; and Camille Vidal, Vice President of Regulatory Affairs, Digital, at GE HealthCare. Regulatory bodies will be well-represented by experts like Ib Alstrup from the Danish Medicines Agency, Tracey Duffy from Australia’s Therapeutic Goods Administration, Woei Jiuang Wong from the Health Sciences Authority, and Nada Alkhayat, Policy Officer and International Lead at the European Commission. The WHO’s own Lead AI, Sameer Pujari, from its Geneva headquarters, will also contribute to the discussions. This diverse lineup underscores the comprehensive effort to address the complex challenges and opportunities presented by AI in healthcare.
Also Read:
- Advancing Ethical AI in Healthcare and Life Sciences: AWS Emphasizes Responsible Design
- DataGrail Summit Emphasizes Automation and Guardrails for Responsible AI Amidst Privacy Concerns
AIRIS 2025 is anticipated to be a landmark event in shaping the future of AI regulation, fostering international collaboration, and guiding the responsible adoption of AI technologies to enhance medical product safety and efficacy worldwide.
